Competitor Analysis: Cardiovascular Peptides -

The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.


Table of Contents

  • 2013 Sales of Major Cardiovascular Peptides
  • Acute Care & Reperfusion Injuries
  • Heart Failure
  • Coronary Ischemia & Myocardial Infarction
  • Cardiometabolic Disease & Atherosclerosis
  • Peripheral Vascular Disease
  • Hypertension
  • Pulmonary Artery Hypertension
  • Hemostasis, Wound Sealing & Prevention of Thrombosis
  • Hematologic Diseases
  • Corporate Cardiovascular Peptide R&D Pipelines